Navigation Links
New Clinical Trial Shows Ascenta Skin Supplement Improves Skin's Resistance to UV Exposure
Date:8/7/2014

Los Angeles, CA (PRWEB) August 07, 2014

Ascenta Health is proud to announce that their revolutionary dietary supplement Ascenta Skin has been clinically shown to increase the skin’s natural protection against ultraviolet (UV) radiation, the leading cause of skin damage and accelerated skin aging.

A recent clinical trial studied the effects of UV exposure on participants who took 4 capsules of Ascenta Skin daily over an eight week period. The results were astounding! Participants displayed on average an 83.8% increase in the UV exposure needed to produce the skin reddening effect that we consider sunburn after just eight weeks.

Sunburn, or reddening of the skin, is an acute skin response to excess UV exposure. Caused by both UVA and UVB, sunburn can be painful and damaging to your skin after you have overexposed yourself to the sun. The accumulated damage accelerates skin aging characterized by an increase in sagging, wrinkling, uneven tone and sun spots. Ascenta Skin’s unique formula of 6 naturally derived active ingredients including Omega-3’s and powerful antioxidants may be the next step in sun protection from the inside out.

“Because Ascenta Skin works from the inside out it produces dramatic results not typically seen with topical skin care products. By simply adding Ascenta Skin to their current skin care regimen consumers are experiencing firmer, smoother, younger looking skin,” says Marc St-Onge, Ascenta Health CEO and creator of Ascenta Skin. “The added benefit of enhanced UV protection proves that healthy, beautiful skin starts from within.”

Conducted at Consumer Product Testing Company, a laboratory at the forefront of sun protection testing, the research featured 28 participants that completed the trial. These participants had their minimal erythemal dose (MED), the smallest dose of UV radiation that produces skin redness, recorded at the beginning of the study. After taking Ascenta Skin daily, their results were measured at the four and eight week markers.

During the first 4 weeks, their MED increased by an average of 39.1% which seemed significant until the results were in for the full eight week period. The increase after 8 weeks of 83.8% in the UV exposure needed to produce reddened skin supports the theory that Ascenta Skin has a UV protective effect on your skin.

Ascenta Skin features 6 active ingredients including DHA, EPA, GLA, Zeaxanthin, Lutein and Vitamin D. In addition to reducing the effects of UV damage, Ascenta Skin is government approved in Canada to increase skin elasticity and firmness, hydration, and reduce roughness and redness including atopic dermatitis. Ascenta Skin’s “Beauty from Within” formula is a game changer in the skin care industry, all natural, science based, amazing skin care results and now UV protection. While Ascenta Skin significantly increases your skin’s resistance to UV it is not intended as a replacement for appropriate use of topical sunscreens.

Ascenta Skin is available to purchase on AscentaSkin.com and at renowned spas throughout Canada. Coming soon to cities across America, Ascenta Skin is currently available at Space.NK.Apothecary in New York and Los Angeles.

For more information on Ascenta Skin and to see remarkable before and after images, please visit http://www.AscentaSkin.com.

Read the full story at http://www.prweb.com/releases/AscentaSkin/08/prweb12078745.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. First targeted nanomedicine to enter human clinical studies
2. Clinical insight improves treatment with new lung cancer drug
3. Clinical news alert from the American Academy of Orthopaedic Surgeons
4. NYU Langone experts present research, clinical advances at neurosurgeons meeting
5. Kroenke honored for outstanding contributions in clinical research training
6. Awards celebrate clinical research that can improve health and alleviate suffering
7. Association for Psychological Science, SAGE launch Clinical Psychological Science
8. URMC clinical trial tests new regimen for hypertension
9. Analysis Finds Clinical Trials Often Small, of Poor Quality
10. Automated insulin dosage titration system demonstrates positive clinical study results
11. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: